Joseph Mikhael, MD, discusses treatment selection for early relapse in multiple myeloma.
Joseph Mikhael, MD
Advertisement
Articles by Joseph Mikhael, MD
Joseph Mikhael, MD, discusses novel agents used to treat patients with multiple myeloma.
Joseph Mikhael, MD, discusses remaining challenges in high-risk multiple myeloma.
Joseph Mikhael, MD, discusses unmet needs in triple-class refractory multiple myeloma.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
5